These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Role of biological agents in immune-mediated inflammatory diseases. Efthimiou P; Markenson JA South Med J; 2005 Feb; 98(2):192-204. PubMed ID: 15759950 [TBL] [Abstract][Full Text] [Related]
24. [New drugs and treatment strategies for rheumatoid arthritis]. Fantini F Recenti Prog Med; 2003 Sep; 94(9):361-79. PubMed ID: 12942798 [TBL] [Abstract][Full Text] [Related]
26. Current management: Management of rheumatic diseases in the era of biological anti-rheumatic drugs. Konttinen YT; Seitsalo S; Lehto M; Santavirta S Acta Orthop; 2005 Oct; 76(5):614-9. PubMed ID: 16263606 [No Abstract] [Full Text] [Related]
32. Potential role of pharmacogenetics in anti-TNF treatment of rheumatoid arthritis and Crohn's disease. Kooloos WM; de Jong DJ; Huizinga TW; Guchelaar HJ Drug Discov Today; 2007 Feb; 12(3-4):125-31. PubMed ID: 17275732 [TBL] [Abstract][Full Text] [Related]
33. [Monoclonal antibodies for the treatment of multiple sclerosis]. Sánchez-Seco VG; Casanova Peño I; Arroyo González R Med Clin (Barc); 2014 Dec; 143 Suppl 3():30-4. PubMed ID: 25732947 [TBL] [Abstract][Full Text] [Related]
34. Treatment, management, and monitoring of established rheumatoid arthritis. Bingham CO; Miner MM J Fam Pract; 2007 Oct; 56(10 Suppl Rapid):S1-7; quiz S8. PubMed ID: 17949607 [No Abstract] [Full Text] [Related]
35. Anti-TNF-α agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Silva LC; Ortigosa LC; Benard G Immunotherapy; 2010 Nov; 2(6):817-33. PubMed ID: 21091114 [TBL] [Abstract][Full Text] [Related]